Augusta (Georgia) [US], April 30 (ANI): About one-fifth of the often fatal head and neck cancers contain gene mutations in pathways important for normal cell proliferation, according to the Medical College of Georgia at Augusta University. Scientists claim that these mutations have the capac
Ohio [US], March 5 (ANI): By adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features increased, suggests a recently conducted clinical trial by the University of Cincinnati.
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
Brisbane [Australia], August 1 (ANI): Discovery of new cellular immunotherapy that targets a deadly type of head and neck cancer, caused by human papillomavirus (HPV), could lead to better survival rates, said Queensland scientists.
Brisbane [Australia], July 28 (ANI): Queensland scientists say the discovery of new cellular immunotherapy that targets a deadly type of head and neck cancer, caused by human papillomavirus (HPV), could lead to better survival rates.